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Executive Summary 
 Antibiotic resistant infections are a growing problem in the United States and the 
world. The main cause of this is antibiotic prescriptions, which can not only cause antibiotic 
resistance but adverse events. Decreasing the amount of antibiotics prescribed for inappropriate 
conditions can help to decrease the rates of antibiotic resistant infections and the problems these 
infections can cause. One illness that is treated frequently with antibiotics, against 
recommendations, is acute bronchitis. Acute bronchitis is a self-limiting viral infection, 
characterized by cough. By decreasing the number of providers who are prescribing antibiotics 
for acute bronchitis, the clinic can help to prevent the chance of antibiotic resistant infections and 
adverse events. Another benefit is getting all the providers to treat patients the same for this 
illness. Currently, when one provider doesn’t give the patient what they want, they may be able 
to see another, who may prescribe an antibiotic. 
This project will be accomplished though a training session with all providers and will 
include clinic staff. Providers will need to take a pre and post training assessment to evaluate the 
effectiveness. Providers and staff will be presented with a PowerPoint lesson on acute bronchitis, 
treatment options, antibiotic effectiveness, and improvement timeframes with antibiotics.  
Providers may feel the need to give patients what they are requesting due to time constraints, 
patient satisfaction scores, fear of complications, and legal concerns (Evertsen et al., 2010). 
Educating providers and staff will provide them with the resources needed to explain why 
patients will not receive an antibiotic.  
Success will be determined by reduced prescribed antibiotic scores, and a 50% reduction 
in the amount of antibiotic prescribed for acute bronchitis. If it works well in the Operational 
Medicine Clinic it can be expanded to the rest of the facility.  
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Treatment of Acute Bronchitis in Active Duty Military Members Benchmark Project 
Rationale 
 Antibiotic resistance infections affect millions of people every year and cause numerous 
deaths. Antibiotic use can cause many problems from allergic reactions to antibiotic resistant 
infections. The National Action Plan for Combating Antibiotic-Resistant Bacteria, created by the 
White House in 2015, set a goal to reduce inappropriate antibiotic use by 50% in the outpatient 
setting by 2020, with over 262 million antibiotic prescription dispensed in 2011 (Fleming-Dutra 
et al., 2016). Inappropriate antibiotic prescribing has been an issue in the United States for years. 
This caused the Centers for Disease Control and Prevention (CDC) to create a campaign in 1995 
to combat inappropriate prescribing called the National Campaign for Appropriate Antibiotic 
Use in the Community, later called Get Smart: Know When Antibiotics Work (Schroeck et al., 
2015; Fleming-Dutra et al., 2016). With the Get Smart campaign name change, a national media 
campaign was launched to inform providers and the general population about the risks associated 
with antibiotics. One of the most common diagnosis associated with inappropriate antibiotic 
prescribing is acute bronchitis.  Acute bronchitis is a self-limiting viral respiratory disease. The 
main symptom of bronchitis is cough, which may or may not be associated with respiratory 
secretions.  Acute bronchitis tends to be prescribed antibiotics despite recommendations that 
acute bronchitis not be treated with antibiotics. A healthcare effectiveness data and information 
set (HEDIS), which is used by many insurance plans as a performance measurement tool, was 
incorporated in 2006 measuring the avoidance of antibiotic treatment in adults with acute 
bronchitis (CDC, 2020). The mean rate of performance was 23% in 2012, across all health plans, 
compared to a goal of 100% (CDC, 2020). Ensuring that providers at Mountain Home Air Force 
Base Warrior Operational Medicine Clinic are aware of the literature suggesting that antibiotics 
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are not necessary for acute bronchitis can help to decrease the rate of antibiotic prescriptions 
seen within the facility.   
Project Goals 
 The goal of this benchmark project is to decrease the number of prescriptions being 
written for antibiotics for acute bronchitis by educating medical providers and staff. Antibiotic 
resistance is increasing due to the overprescribing of antibiotics, and one way to combat that is to 
properly prescribe antibiotics. As providers leave medical school, it becomes the responsibility 
of the provider to stay on top of current treatments and recommendations for all sorts of disease 
processes. While the treatment for acute bronchitis hasn’t changed in years, providers have to 
deal with patients who believe they know what is best, and what they need. Provider can get 
caught in a limbo of proper medical care and the needs and desires of the patient and the 
organization. Many different factors contribute to a provider prescribing an antibiotic for acute 
bronchitis including patient expectations, clinical error, office location, workload, and legal 
consideration (Evertsen et al., 2010; Sanchez et al., 2014; Schroeck et al., 2015).  One major 
concern with patients believing in the need for antibiotic treatment is the mismatch between 
perceptions of how long the cough can last. Patients report that a cough lasts between 6.5 to 9.2 
days, while coughs in reality can last up to an average of 18 days, this can cause patients to 
return to the provider to request an antibiotic (Ebell et al., 2013).   
 The goal of this benchmark study is to improve the education and resources available to 
providers to reduce the number of antibiotic prescriptions written for acute bronchitis. If 
providers are more aware of the disease process and the information available about the 
symptoms of acute bronchitis, providers will be better equipped to inform patients and give them 
materials that can help to increase awareness. Patients will then be more aware of the risks 
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associated with antibiotic misuse. By creating a culture of antibiotic stewardship, patients will 
begin to gain the knowledge that antibiotics are not used for every illness, and thus will no longer 
expect an antibiotic at every visit. By educating the providers and staff about the treatment for 
acute bronchitis and appropriate antibiotic prescribing, a trickle-down effect may occur creating 
a better environment for antibiotic prescribing overall.  
Literature Synthesis 
 Completing a literature search to determine the implications of antibiotics on acute 
bronchitis brought up many results. Researchers have been working on determining why 
antibiotics are still overprescribed and whether a difference in symptoms are seen with those who 
take antibiotics compared to those who go without. According to Link et al. (2016) the urgent 
care in the quality improvement study saw over 18,500 patients with acute bronchitis and treated 
them inappropriately with antibiotics in 96% of the cases, while Kroening-Roche et al. (2011) 
found that in the emergency room antibiotics are being prescribed for acute bronchitis between 
57%-97% of the time, and Schroeck et al. (2015) in a retrospective chart review found that only 
20.5% of patients with acute bronchitis were treated appropriately based on the 
recommendations from the CDC’s Get Smart Campaign. Evertsen et al. (2010) found, in a 
retrospective chart review of 604 patients, that 93% with acute bronchitis were prescribed 
antibiotics, and Barnett and Linder (2014) found that the rate of prescribing had increased from 
1996-2010, and was being prescribed 71% of the time. In contrast to other studies, a study 
looking into quality improvement in Denmark found that only 23% of patients with acute 
bronchitis were prescribed antibiotics (Saust et al., 2018), while this is an overuse of antibiotics 
for bronchitis, the findings suggest that Denmark has better control of the bronchitis prescribing 
rates than some other countries.   
BRONCHITIS TREATMENT IN AD MILITARY 8 
 
 Some of the articles reviewed symptoms found in acute bronchitis and whether 
antibiotics decreased or improved these symptoms.  In the 13-country observation study 
conducted by Butler et al. (2010), over 2600 people participated and the group who were not 
prescribed antibiotics felt recovered sooner than those taking amoxicillin, but not sooner than 
other classes of antibiotics. All classes of antibiotics and no treatment groups had a mean day felt 
recovered within 3 days of one another (Butler et al., 2010). Overall, this study showed that no 
class of antibiotics and no treatment was better at reducing symptoms for acute lower respiratory 
tract infections/acute cough illnesses over another (Butler et al., 2010). This study did not discuss 
the ill effects that can happen from taking inappropriate antibiotics.  In the single blinded 
randomized placebo-controlled study done by Llor et al. (2013) patients were given amoxicillin-
clavulanic acid three times daily, ibuprofen 600 mg three times daily, or a placebo three times 
daily for treatment of acute non-complicated bronchitis with discolored sputum. The study 
looked at 371 people and ibuprofen had the quickest resolution of frequent cough with a mean 
duration of 9, compared to 11 with amoxicillin, and 10 with the placebo, though no statistical 
significance was found (Llor et al., 2013). Little et al. (2013) conducted a similar placebo-
controlled trial, utilizing amoxicillin in the treatment group and a placebo in the control group 
with similar results, “moderately bad” symptoms resolved one day sooner in the treatment group. 
In the study by Llor et al. (2013) Ibuprofen was shown to reduce the amount of symptom 
duration compared to antibiotic treatment and the placebo, which had the longest duration of 
symptoms, even though there was no statistical significance, which was in contrast to the study 
done by Butler et al. (2010), which showed there was no difference in symptom resolution 
between antibiotic treatment and no antibiotic treatment, while Evertsen et al. (2010) reports that 
antibiotics do decrease the duration of symptoms, but only by half a day in healthy adult patients 
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with acute bronchitis. The Cochrane Review had mixed results across the study with a few 
showing slight benefits for antibiotic treatments, though none were of clinical significance 
(Smith et al., 2017).  
 Incorrect antibiotic prescriptions were more likely to be seen in patients with cough and 
penicillin allergies, while tonsillar exudate, lymphadenopathy, and fever were associated with 
appropriate treatment (Schroeck et al., 2015). Ebell et al. (2013) found that patient expectations 
for cough duration were way lower than the average duration of cough during an acute cough 
illness, and could help to explain the expectation of an antibiotic prescription during follow-up 
care. Fleming-Dutra et al. (2016) utilized the NAMCS and NHAMCS to review statistics of 
antibiotic prescribing for all ambulatory care visits reported, finding that half of the antibiotics 
prescribed for acute respiratory conditions may have been inappropriate. The same study in a 
review of literature found that the United States prescribed almost 550 more antibiotics per 1,000 
people than Sweden, with Sweden not increasing in side effects of the illness (Fleming-Dura et 
al., 2016). Nausea, rash, and diarrhea was found to be more frequent in patients prescribed 
antibiotics (Little et al., 2013; Smith et al., 2017). Overprescribing antibiotics, or using them for 
inappropriate diagnoses, can cause gastrointestinal issues, eliminate antibiotic susceptible 
organisms which allow the resistant organisms to expand, and can pass the genes for antibiotic 
resistance between the bacteria (Fiore et al., 2017).  Lesser known is that antibiotic prescriptions 
can affect the stress response, increase the chances of childhood obesity in children younger than 
24 months, and may have an effect on the immune tolerance of those with asthma (Fiore et al., 
2017).  According to the Cochrane Review completed by Smith et al. (2017), all of the studies 
reviewed with the exception of four, showed more adverse events with antibiotic treatment than 
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patients receiving a placebo. All adverse events were mild, but enough to cause providers pause 
in the need to prescribe antibiotics (Smith et al., 2017).  
Stakeholders 
 The main people affected by this change process are the patients. Patients in the military 
practice setting come to the clinic to be seen and to feel better. Patients want to ensure that the 
provider is listening to the concerns and issues brought by the patient, and is working to correct 
them. Patients tend to already know what they want to be done and providers either have to 
spend time trying to explain why that is not necessary or face the pressure to order treatment that 
is not necessary.   
 Additional stakeholders in the organization are the providers, technicians, and staff 
working in the clinic. Each member of the team will be responsible for answering questions 
about why antibiotics were not prescribed and how this affects each patient. Leadership may 
receive phone calls from work centers as to why patients are not improving and why treatment 
has been refused. Leadership will also see the benefits from the project with decreased antibiotic 
prescribing rates. The insurance companies will be stakeholders due to paying for the antibiotics 
and possibly reporting the data from these prescriptions and diagnosis to HEDIS measurements.  
Implementation 
The location for the plan is the Operational Medicine Clinic (OMC) of Mountain Home 
Air Force Base, located in Mountain Home, ID. This clinic incorporates the Warrior Operational 
Medicine Clinic (WOMC), Flight Operational Medicine Clinic (FOMC), and the Base 
Operational Medicine Clinic (BOMC). Between these three clinics the entire population of active 
duty members, as well as Guard and Reserve members on the base, are seen. It will be 
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implemented in order to ensure that all members are receiving the same type of care no matter 
which clinic or provider seen for treatment of acute bronchitis.  
Permission from the Medical Treatment Facility Director and Executive Staff will need to 
be received prior to the planning and implementation stage of the project. An important step in 
planning is ensuring that all staff and leaders who may be affected in this change are involved in 
the process (Hockenberry et al., 2015). The changes will impact the clinic mostly, but may have 
some impact on pharmacy and radiology as well.  
Once approval is received, a team will need to be compiled to complete the change 
project. Project boards are located in each clinic in order for staff to see what the clinic is 
working on, and to help out with suggestions. Working with different specialties will create an 
impediment to project meetings due to the schedules of those involved. Creating a time for 
meetings that works between every member will need to be determined.  
In order to evaluate the education of the providers a test will be completed in order to 
determine their level of education regarding antibiotic prescriptions for acute bronchitis. The 
same evaluation will be completed after training on why antibiotics should not be prescribed for 
acute bronchitis and scores will be compared. Questions have not been written at the time of this 
benchmark study but will be completed during the planning stage of the project. Providers will 
be presented with a 30-minute PowerPoint on the evidence-based guidelines for acute bronchitis 
and treatment options, created by the Project Leader with help from Team Members. The 
PowerPoint presentation will also discuss the different studies showing little to no improvement 
in symptoms or time before returning to baseline with antibiotics versus placebos. The studies 
showing increase in side effects from the antibiotics will be discussed, as well as the side effects 
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found. Team members will need to create the pre-and-post test, as well as refine the PowerPoint 
to ensure it catches and keeps the attention of the providers in attendance.  
Tracking of the project success will be completed by the pre- and post-test scores, as well 
as a report on the antibiotic prescriptions pre- and post-implementation. Implementation of the 
project facility wide can be discussed after results from OMC are received. Changes may need to 
be made for facility wide implementation due to difference in patient population and acuity 
levels.  
Timetable/Flowchart 
 The project can be completed in 4-6 months depending on the start schedule due 
to certain meetings only occurring monthly, and others only quarterly. Project length will need to 
be adjusted depending on the season of the year, as bronchitis isn’t as common in summer 
months.  Getting approval to begin may take the longest as it needs to be presented through 
multiple channels before receiving the approval of the Director and Executive Staff. The 
Executive staff meet weekly so getting on the schedule to present can happen, after approval 
from clinical leadership and Squadron Leadership. Every approval will take about a week to get 
in order to schedule meetings, present, and then get on the schedule for the next level approval, 
as long as extenuating circumstances are not present. Recruiting staff from clinic, as well as 
support staff from radiology and pharmacy can take up to one month to recruit and then plan the 
questions for the pre- and post-test. PowerPoint creation will take 2 weeks, and scheduling for 
the presentation can vary from the following week up to 6 weeks later, due to meeting times. 
Running of reports prior to implementation will be completed one week prior to implementation 
and for a 2-month timeframe, if available, and length of report may be changed based on season 
of the year. Pre-test, PowerPoint, and post-test will take an hour during a scheduled meeting.  
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Antibiotic prescriptions will be reviewed for a 2-month period after implementation, adjusting 
for seasons as needed.  Manual chart reviews, if needed, will be reviewed for the 2 months post 
training, and will take up to 2 weeks depending on the number of patients diagnosed and staff 
reviewing.  
 
Data Collection Methods 
 Data collection will be completed through reports compiled through the pharmacy on the 
antibiotic prescribing practices of the providers individually and as a group. The charting system 
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used in the military treatment facility is Genesis. Genesis reports will be pulled, if able, to 
determine patients with the diagnosis of acute bronchitis and the treatment plan completed. Pre 
and post test results will be calculated and evaluated by the project team. Discussions will be 
help on a one-by-one basis between team members and staff on the impact the project has had on 
the workflow of the clinic.    
Cost/Benefit  
 There will be little cost to this project. Overall, the cost involved would be time away 
from work centers for the project team members, as well as costs involved with taking the 
providers away from their work centers while doing the training. Providers may have little time 
away from patients due to an implemented training day once a month in the morning that may be 
able to be used for the training time.  
 The benefits of this project are numerous. Implementing this evidence-based project can 
create reduced costs associated with antibiotics. By not ordering as much antibiotics, the 
pharmacy can reduce the amount it keeps on hand, thus reducing storage overhead. Since the 
facility is small, this will only result in a small decrease in costs. Eliminating the risks of adverse 
events from antibiotic prescriptions can reduce costs to the facility. Since this project will be 
implemented in the clinic working with active duty members, no cost savings will be felt by the 
patients as well, since insurance for active duty members is fairly all-encompassing.  
 The benefit from this project will not be in cost savings, but rather in education savings. 
Providers will now be better informed on antibiotic stewardship for acute bronchitis and will be 
passing this information on to patients. Patients in turn may tell others, which can create a 
conversation about antibiotics. The reduction in antibiotic prescriptions will be shown in the 
results of each provider which is reported at the pro-staff meeting, which is a meeting for all 
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credentialed, privileged staff. This reduction will also reflect highly on the facility in reports to 
Tricare, the military health insurance.  
Evaluation 
The evaluation for this evidence base project will consist of a pre-and-post test for the 
education portion of the project, and comparing antibiotic prescription rates for acute bronchitis 
prior to project implementation and after. Providers will be handed a 10-question multiple choice 
and true/false test to take on acute bronchitis etiology, symptoms, and treatment prior to 
educational session. While providers will have signed in, in order to get credit for attending the 
session, color-coded tests will be used to keep the test anonymous. Two tests will be provided to 
each provider, so that scores can be calculated and determined based on pre and post test scores. 
These tests will be evaluated using a paired t test. Test questions have not been prepared during 
this benchmark project, but will be completed once leadership approval is granted during the 
planning phase. Data will be collected for 2 months prior to education session and for two 
months after, depending on the season of implementation. All diagnosis related to acute 
bronchitis will be reviewed and included or excluded based on inclusion criteria. We will 
determine the number of patients seen with acute bronchitis, as well as the number of patients 
where antibiotics were prescribed, looking at the antibiotic prescribed for patients with any of the 
diagnosis of acute bronchitis. Data for whether antibiotics were prescribed or not will be 
analyzed using the Fisher’s exact test. Success will be determined by all providers having a score 
of 80% or greater on the post test for the education portion and antibiotic prescription rates 
decreasing by at least 50% for acute bronchitis.  Pharmacy will need to be involved in running 
the antibiotic reports, as well as in determining if it can be run by certain diagnosis only. Genesis 
coordinators may be involved in determining how records can be pulled to review medications 
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ordered on acute bronchitis. Due to the smaller scale of the clinic, manual reviews of charts, 
based on diagnosis, can be completed to determine treatment plan and medication prescribed if 
necessary. 
Evaluation Steps 
1. Compare pre and post test scores from the test each provider completed at the education 
session.  
2. Determine if each provider increased their knowledge, and if everyone passed with at 
least 80% on the post test.  
3. Complete a paired t test on the scores. 
4. Compare antibiotic prescription data from prior to implementation and after.  
5. Determine significance by performing Fisher’s exact test.  
6. Determine whether results were significant. 
Conclusion/Recommendations 
 Working to reduce the impact of antibiotic resistant infections is a goal set forth by the 
White House to be achieved prior to 2020 (Fleming-Dutra et al., 2016). While 2020 is past, it is 
still a topic that needs addressed. By working to reduce the antibiotics prescribed by providers 
within the Operational Medicine Clinic for acute bronchitis, the Military Treatment Facility is 
making a step to reducing inappropriate antibiotic prescribing. Education and evaluation can be 
performed at a minimal cost to the facility, in both time and manpower, if utilizing already set 
training times. If this project is a success, recommendations would be to expand it facility wide. 
If vast improvements are seen, enlarge this project to encompass the Defense Health Agency 
military facilities.   
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